Sonova Holding AG, CH0012549785

Sonova stock trades at EUR 265.70 as earnings growth strengthens

Published on 09/29/2026 at 13:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock was trading at EUR 265.70 on September 29, 2026. FY 2025/26 sales rose 5.90 percent, while normalized EBITDA increased 17.30 percent.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti
Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova stock (ISIN CH0012549785) was trading at EUR 265.70 at Lang & Schwarz on September 29, 2026 at 1:01 p.m. CEST. The price comes as the hearing-care group combines stronger profitability with a fresh product cycle in its core hearing-instrument business.

Sales and profit accelerate

According to Sonova in its fiscal-year 2025/26 results dated May 18, 2026, group sales reached CHF 3,605.90 million, up 5.90 percent in local currencies. The result gives the stock a fundamental base beyond the current quotation.

Normalized EBITDA rose 17.30 percent to CHF 794.00 million, while the margin reached 23.70 percent and improved by 280 basis points in the hearing-instruments segment, according to Yahoo Finance on May 18, 2026. Profit growth therefore outpaced sales growth, highlighting operating leverage as a central part of the investment case.

Phonak drives the product cycle

Sonova launched the Phonak EON hearing-aid portfolio on August 24, 2026. The platform combines a HYPERSONIC chip, AI-based speech processing and Made-For-All connectivity, according to Sonova.

The latest earnings call also put the product strategy into numbers: hearing-instrument sales rose 7.50 percent to CHF 3.40 billion in fiscal year 2025/26, while wholesale revenue increased 9.50 percent to CHF 1.90 billion. Retail revenue reached CHF 1.50 billion, up 5.10 percent, creating a broader growth contribution than hardware launches alone.

Stock reaches a yearly high

Sonova's SIX quote reached CHF 250.60 on September 29, 2026, setting a 52-week high. The share price context matters because the latest reported figures show both sales expansion and a 17.30 percent increase in normalized EBITDA.

At Lang & Schwarz, Sonova stock was trading at EUR 265.70 on September 29, 2026 at 1:01 p.m. CEST. The quotation is intraday and the available Lang & Schwarz snapshot does not provide a valid prior-close comparison.

Sonova stock facts

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SOON
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of September 29, 2026, 1:01 p.m. CEST): EUR 265.70
  • Sector / Industry: Healthcare / Medical Devices

More news and analyses on Sonova stock

Disclaimer...

en | CH0012549785 | SONOVA HOLDING AG | boerse | 70197632 | bgmi